LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

02/10/2020
PRESS RELEASE

#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.

Brussels, 2 October 2020 – The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) will start on Monday in a new fully digital format, providing 5 days of insights and engagements.

Now in its 13th edition, the conference continues to attract leading industry and policy experts to discuss opportunities and challenges for these transformative technologies. This year the Forum will have a special focus on how biotechnology innovation can help advance the Green Economy. Six main topics will be highlighted during EFIB: 1) Green. Circular. Sustainable; 2) Food, Feed & Nutrition; 3) Fashion & Textiles; 4) Financing & Investment; 5) Materials & Packaging; and 6) Bioprocesses & Technologies. “This week’s celebrations of the first fully digital Biotech Week provide an ideal lead-in to #EFIB2020, which launches on Monday. This year EFIB is also in a digital setting and we are looking forward to celebrating the sector’s latest achievements in harnessing the power of innovation to help deliver new solutions,” said Agnes Borg, Industrial Biotechnology Director at EuropaBio.

This year’s agenda will amongst others feature Director-General of DG GROW Kerstin Jorna, Forum for the Future CEO Dr Sally Uren OBE and Susanne Pedersen, Assistant Director-General and head of Investment and Policy Solutions of the Global Green Growth Institute. Other speakers will include leading executives from companies such as DSM, Novozymes, Givaudan, Cargill, Stora Enso, and Lenzing as well as distinguished speakers from the European Commission, the European Food Safety Authority, the European Circular Bioeconomy Fund, the Laudes Foundation, and many more. The agenda will also feature perspectives on how industry can help drive the SDG agenda forward, a session looking to the future of biotechnology innovation in Europe co-organised with the European Federation of Biotechnology, and much more!

#EFIB2020 participants will also be able to engage with innovators from start-ups and academia through the Digital Start-Up Forum and the Innovation Campus digital academic poster presentations. A winner for both the Start-Up Forum and Innovation Campus will be announced at the end of the conference week.

For more information about EFIB2020, please visit our website.

EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference


Download
Share
Communications Team
Communications Team

Related posts

12/11/2025

EuropaBio response to the EU Biotech Act public consultation


Read more
05/11/2025

EuropaBio recommendations for the Circular Economy Act


Read more
31/10/2025

Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines


Read more

Important links

  • EuropaBio response to the EU Biotech Act public consultation
  • EuropaBio recommendations for the Circular Economy Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.